# Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

> **NCT04614714** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **University of California, Davis** · enrollment: 40 (estimated)

## Conditions studied

- Preterm Birth
- Inadequate Milk Production

## Interventions

- **OTHER:** Nicotinamide Riboside (NR)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04614714
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614714, "Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04614714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*